T2 Biosystems to Report Third Quarter 2022 Financial Results on November 10, 2022
October 31 2022 - 5:56PM
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid
detection of sepsis-causing pathogens and antibiotic resistance
genes, announced today that it will report financial results for
the third quarter 2022 after market close on
Thursday, November 10, 2022. Company management will host a
corresponding conference call beginning at 4:30 p.m. Eastern
Time.
Investors interested in listening to the
conference call may do so by accessing a live and archived webcast
of the event at www.t2biosystems.com, on the Investors page in
the Events & Presentations section.
About T2 Biosystems:T2
Biosystems, a leader in the rapid detection of sepsis-causing
pathogens and antibiotic resistance genes, is dedicated to
improving patient care and reducing the cost of care by helping
clinicians effectively treat patients faster than ever before. T2
Biosystems’ products include the T2Dx® Instrument, T2Bacteria®
Panel, T2Candida® Panel, T2Resistance® Panel, and T2SARS-CoV-2™
Panel and are powered by the Company’s proprietary T2 Magnetic
Resonance (T2MR®) technology. T2 Biosystems has an active pipeline
of future products, including the T2Biothreat Panel, T2Cauris™
Panel, T2Lyme™ Panel, as well as additional products for the
detection of bacterial and fungal pathogens and associated
antimicrobial resistance markers. For more information, please
visit www.t2biosystems.com.
Investor Contact:Philip Trip Taylor, Gilmartin
Groupir@T2Biosystems.com415-937-5406
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Mar 2024 to Apr 2024
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Apr 2023 to Apr 2024